Molecular characterisation and liquid biomarkers in Carcinoma of Unknown Primary (CUP): taking the 'U'out of 'CUP'

AM Conway, C Mitchell, E Kilgour, G Brady… - British journal of …, 2019 - nature.com
Abstract Cancers of Unknown Primary (CUP) comprise a heterogeneous clinical entity of
confirmed metastatic cancer where the primary site of origin is undetectable. It has a poor …

Cancer of unknown primary in the molecular era

S Kato, A Alsafar, V Walavalkar, J Hainsworth… - Trends in cancer, 2021 - cell.com
Cancer of unknown primary (CUP) is a rare malignancy that presents with metastatic
disease and no identifiable site of origin. Most patients have unfavorable features and …

[HTML][HTML] Comprehensive analysis of cancers of unknown primary for the biomarkers of response to immune checkpoint blockade therapy

Z Gatalica, J Xiu, J Swensen, S Vranic - European journal of cancer, 2018 - Elsevier
Background Cancer of unknown primary (CUP) accounts for approximately 3% of all
malignancies. Avoiding immune destruction is a major cancer characteristic and therapies …

New rising entities in cancer of unknown primary: Is there a real therapeutic benefit?

E Rassy, P Parent, F Lefort, S Boussios… - Critical reviews in …, 2020 - Elsevier
Abstract Cancers of Unknown Primary Site (CUP) account for approximately 1–3% of all
malignant neoplasms. It represents a heterogeneous group of malignancies without a …

[HTML][HTML] Redefining cancer of unknown primary: Is precision medicine really shifting the paradigm?

T Olivier, E Fernandez, I Labidi-Galy, PY Dietrich… - Cancer treatment …, 2021 - Elsevier
The concept of Cancer of Unknown Primary (CUP) has evolved with the advent of medical
oncology. CUP can be difficult to diagnose and represents 2 to 5% of new cancers, therefore …

Cancer of unknown primary: challenges and progress in clinical management

N Laprovitera, M Riefolo, E Ambrosini, C Klec… - Cancers, 2021 - mdpi.com
Simple Summary Patients with cancer of unknown primary site suffer the burden of an
uncertain disease, which is characterized by the impossibility to identify the tissue where the …

“Metastatic cancer of unknown primary” or “primary metastatic cancer”?

S Kolling, F Ventre, E Geuna, M Milan… - Frontiers in …, 2020 - frontiersin.org
Cancer of unknown primary (CUP) is an umbrella term used to classify a heterogeneous
group of metastatic cancers based on the absence of an identifiable primary tumor …

[HTML][HTML] Comprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: analysis of 1806 cases

Z Gatalica, SZ Millis, S Vranic, R Bender, GD Basu… - Oncotarget, 2014 - ncbi.nlm.nih.gov
Background Cancer of unknown primary (CUP) accounts for approximately 3% of all
malignancies. Despite extensive laboratory and imaging efforts, the primary site usually …

[HTML][HTML] Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics

LJ Schipper, KG Samsom, P Snaebjornsson… - ESMO open, 2022 - Elsevier
Background In∼ 3%-5% of patients with metastatic disease, tumor origin remains unknown
despite modern imaging techniques and extensive pathology work-up. With long diagnostic …

Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of care

JD Hainsworth, FA Greco - Virchows Archiv, 2014 - Springer
Carcinoma of unknown primary site (CUP) is diagnosed in approximately 3% of patients with
advanced cancer, and most patients have traditionally been treated with empiric …